Pharmacies: Make your medication adherence program more cost-efficient
Looking to improve patient intervention outcomes and quality performance?
AllazoHealth’s AI engine accurately targets individual patients who are both at risk of non-adherence and whose behavior can be positively influenced by interventions. The AI engine then predicts the most effective intervention, personalized by channel, content, and timing.
The result: improved clinical outcomes and increased reimbursement from pay-for-performance contracts such as DIR.
Make DIR contracts more productive
Adherence is a key measure in all DIR contracts. So improving medication adherence can have a dramatic impact on your reimbursement from payers.
And when it comes to DIR contracts, pharmacies need to improve performance every year just to keep pace. AllazoHealth’s AI engine gets smarter over time because it continually learns from new data. So your adherence program will keep improving and delivering more value.
Benefits of AI-powered patient engagement
Leading pharmacy improves both cost efficiency and effectiveness of patient interventions
Outcome: Increased fill rate
Learn how a national retail pharmacy used artificial intelligence (AI) to generate a 2.3 times uplift in medication adherence. At the same time they improved targeting of patient interventions to make them more cost-effective.
Improving diabetes adherence: pharmacies, Medicare Advantage Plans and AI
In the field of chronic diseases, Type 2 diabetes ranks high when it comes to the challenges of therapy initiation and non-adherence. Diabetes accounts for…
Advances in patient interventions: How to manage complexity
Patient adherence programs are continually searching for more cost-effective interventions that improve clinical outcomes. Tactics have expanded beyond outreach by phone call to digital channels…
The challenge of mental health drug non-adherence
Major mental health disorders are some of the most difficult conditions to manage. According to a retrospective analysis in Systematic Reviews, almost 450 million people…